Malignant Testicular Neoplasm clinical trials
25 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
- A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
- ARC101 in Advanced Solid Tumors
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Brodalumab in the Treatment of Immune-Related Adverse Events
- A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
- A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
- Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
- Navigation Intervention for Adolescent and Young Adult Cancer Survivors
- Urologic Lymphadenectomy in AMIGO
- DESTINY-PANTUMOUR04
- DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- Integrated Cancer Repository for Cancer Research
- Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
- A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
- Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
- Improving Health Insurance Literacy Among Young Adult Cancer Survivors
- Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- Unveiling Patient Experiences in Testicular Cancer Clinical Trials
- Virtual Testis Cancer Lay Support and Survivorship Aim 2
- Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Malignant Testicular Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.